Safety, Efficacy, and Bioavailability of Fixed-Dose Combinations in Type 2 Diabetes Mellitus: A Systematic Updated Review.

Curr Ther Res Clin Exp · 2017 · PMC5522976 · PMID 28761573

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

An open-label, prospective, multicenter observational study conducted by Ved et al 3 in 2012 on 300 patients with T2DM treated with vildagliptin and metformin FDC showed a highly significant decrease in FBG, postprandial glucose (PPG), and HbA 1c values from the baseline at the end of 3 months.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.